5.70
111 Inc Adr stock is traded at $5.70, with a volume of 3,158.
It is down -0.52% in the last 24 hours and down -17.03% over the past month.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
See More
Previous Close:
$5.73
Open:
$5.76
24h Volume:
3,158
Relative Volume:
0.23
Market Cap:
$50.14M
Revenue:
$1.75B
Net Income/Loss:
$-9.95M
P/E Ratio:
-5.3733
EPS:
-1.0608
Net Cash Flow:
$16.55M
1W Performance:
-5.00%
1M Performance:
-17.03%
6M Performance:
+55.74%
1Y Performance:
-26.92%
111 Inc Adr Stock (YI) Company Profile
Compare YI vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
YI
111 Inc Adr
|
5.70 | 50.41M | 1.75B | -9.95M | 16.55M | -1.0608 |
|
MCK
Mckesson Corp
|
759.25 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
263.08 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
199.36 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
72.98 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
1.55 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
111 Inc Adr Stock (YI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Resumed | Citigroup | Buy |
111 Inc Adr Stock (YI) Latest News
111 Inc stock (KYG6769N1008): Chinese online pharmacy share under pressure amid shifting healthcare - AD HOC NEWS
Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 - Minichart
Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union
Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading - Moomoo
BASF SE stock (DE000BASF111): dividend profile and business outlook after latest payout - AD HOC NEWS
T. Rowe Price (OS) files 13G/A reporting 111 shares; 0.0% ownership - Stock Titan
KBS Real Estate Investment Trust III (KBSR) warns on going concern amid $1.2B near-term debt load - Stock Titan
111 Inc stock (KYG6769N1008): Analyst upgrade to Hold amid recent price volatility - AD HOC NEWS
RSU awards lift 111, Inc. (YI) director Teo Nee Chuan’s holdings to 811,889 - Stock Titan
Director Chen Yang Luke granted 413,168 RSUs at 111, Inc. (YI) as equity awards - Stock Titan
Large RSU grants to 111, Inc. (YI) director boost reported holdings - Stock Titan
111, Inc. (YI) director granted over 790,000 RSUs in new awards - Stock Titan
Redemption pressure, China rules shape 111, Inc. (NASDAQ: YI) outlook - Stock Titan
Read the full transcript of King Charles III’s speech to U.S. Congress - Global News
How to watch King Charles III’s historic address to Congress live - Fast Company
King Charles US visit: What to know about the itinerary, Congress address - Al Jazeera
AIR merger gives CAEP (NASDAQ: CAEP) holders new Pubco AIIR shares - Stock Titan
King Charles to Honor Queen Elizabeth in Recorded Address in Honor of Her 100th Birthday - People.com
Jian David Sun Net Worth (2026) - GuruFocus
Yang Luke Chen Net Worth (2026) - GuruFocus
Yu Gang Net Worth (2026) - GuruFocus
Nee Chuan Teo Net Worth (2026) - GuruFocus
Jun Justin Luo Net Worth (2026) - GuruFocus
111 (NASDAQ:YI) Shares Up 3.2%Should You Buy? - MarketBeat
111, Inc. Posts 2025 Profitability Milestone as Asset-Light Pivot Lifts Margins - The Globe and Mail
111, Inc. (NASDAQ: YI) trims 2025 revenue while edging toward operating profit - Stock Titan
111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results - The Manila Times
Winter Organization snags pair of leases in Flatiron offices - The Real Deal
111 Inc. (YI) Eps Diluted (TTM) - Zacks Investment Research
Precision Trading with 111 Inc. (YI) Risk Zones - Stock Traders Daily
Hub Group (HUBG) CAO reports 111-share tax withholding and 81-share correction - Stock Titan
YI Stock Analysis: 111 Inc. American Depositary Shares 3.3% Dip to $6.44 Recap - Newser
Insulet (PODD) board member elects 111 deferred stock units as fees - Stock Titan
Ultragenyx (RARE) gets FDA review date for UX111 gene therapy on Sept. 19, 2026 - Stock Titan
King Charles III to address Congress on April 28 - CBS News
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation - Novartis
Walmart makes rare, harsh choice amid 'power buyer' controversy - thestreet.com
America’s Biggest Retailer Walmart to Cut 111 Jobs at Matteson Site - WhatNow
symbol__ Stock Quote Price and Forecast - CNN
111 Inc Stock: Pioneering China's Online Healthcare Retail with Global Investor Potential - AD HOC NEWS
111 Inc Stock: Micro-Cap Healthcare Leader in China's Digital Pharmacy Space Faces Profit Challenges - AD HOC NEWS
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
111 (NASDAQ:YI) Shares Down 2.2%What's Next? - MarketBeat
111, Inc. (YI) director reports 19,984 fully vested RSUs on Form 3 - stocktitan.net
Director Luo Jun Justin reports 18,366 vested RSUs in 111, Inc. (YI) - Stock Titan
111, Inc. (YI) director Sun Jian David reports 18,366 vested RSUs - stocktitan.net
111, Inc. (YI) director Chen Yang Luke reports 126,295 fully vested RSUs - Stock Titan
Liu Junling discloses major equity stake in 111, Inc. (YI) on Form 3 - Stock Titan
Gang Yu details large equity stake in 111, Inc. (YI) Form 3 filing - Stock Titan
111 Inc Stock (ISIN: KYG6769N1008) Faces Headwinds Amid China E-Commerce Slowdown - AD HOC NEWS
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 - GlobeNewswire
111 Inc Adr Stock (YI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):